Why the study?
Does cardiomyocyte-specific deletion of CaMKIIδ reduce Angiotensin II-induced inflammation and fibrosis in mice?
Population
Mice model (cardiomyocyte-specific deletion of CaMKIIδ [CKO] and wild-type controls)
Comparison
Angiotensin II infusion; inhibition of… vs Wild-type mice receiving Ang II infusion
Design
Preclinical
Authors
Loading...
Suggests CaMKIIδ as target in Ang II cardiac inflammation; leaves open translation to human hypertensive heart disease.
Does cardiomyocyte-specific deletion of CaMKIIδ reduce Angiotensin II-induced inflammation and fibrosis in mice?
Demonstrates that CaMKIIδ activation in cardiomyocytes initiates inflammasome activation and inflammatory gene expression, leading to macrophage recruitment and cardiac fibrosis.
Willeford et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: